MAPK3 and lung carcinoma: Liu et al. highlighted the modulation of EMT related effectors, as in lung cancer cells, by the EGCG, having the capacity to inhibit the transforming growth factor β (TGFβ) being induced by the EMT mechanism and the inhibition of the phosphorylated form of Smad2 and ERK1/2 [36].